SCM
CRL icon

Sterling Capital Management’s Charles River Laboratories CRL Stock Holding History

Sterling Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335K Sell
1,475
-162
-10% -$28.8K 0.01% 997
2026
Q1 		$282K Sell
1,637
-1,255
-43% -$233K 0.01% 1009
2025
Q4 		$577K Sell
2,892
-124
-4% -$22.5K 0.01% 872
2025
Q3 		$472K Sell
3,016
-257
-8% -$40.8K 0.01% 954
2025
Q2 		$497K Buy
3,273
+374
+13% +$49.9K 0.01% 921
2025
Q1 		$436K Sell
2,899
-187
-6% -$31.4K 0.01% 904
2024
Q4 		$570K Buy
3,086
+1,080
+54% +$208K 0.01% 835
2024
Q3 		$395K Buy
+2,006
New +$417K 0.01% 987
2016
Q2 		– Sell
-15,670
Closed -$1.19M – 944
2016
Q1 		$1.19M Buy
15,670
+1,804
+13% +$134K 0.01% 481
2015
Q4 		$1.11M Buy
13,866
+2,034
+17% +$147K 0.01% 516
2015
Q3 		$752K Buy
11,832
+600
+5% +$43.1K 0.01% 603
2015
Q2 		$790K Sell
11,232
-5,920
-35% -$438K 0.01% 503
2015
Q1 		$1.36M Sell
17,152
-2,143
-11% -$158K 0.01% 388
2014
Q4 		$1.23M Sell
19,295
-8,756
-31% -$549K 0.01% 606
2014
Q3 		$1.68M Sell
28,051
-2,361
-8% -$135K 0.02% 442
2014
Q2 		$1.63M Buy
30,412
+23,709
+354% +$1.3M 0.01% 428
2014
Q1 		$404K Buy
6,703
+35
+0.5% +$2.04K ﹤0.01% 809
2013
Q4 		$354K Sell
6,668
-14,200
-68% -$713K ﹤0.01% 698
2013
Q3 		$965K Buy
+20,868
New +$958K 0.01% 277

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Sterling Capital Management's CRL Position: Q2 2026 in Review

Sterling Capital Management reduced its Charles River Laboratories (CRL) stake by 9.9% in Q2 2026, selling an estimated $28.8K and leaving 1,475 shares worth $335K. The position accounts for 0.01% of the portfolio, ranked #997.

Sterling Capital Management first reported a position in CRL in Q3 2013 and has held it in 19 quarters since. The position peaked at $1.68M in Q3 2014. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Sterling Capital Management held 1,475 shares of Charles River Laboratories worth $335K as of Q2 2026.
  • Sterling Capital Management sold 162 Charles River Laboratories shares in Q2 2026, an estimated $28.8K.
  • Charles River Laboratories made up 0.01% of Sterling Capital Management's portfolio in Q2 2026, its #997 holding.
  • Sterling Capital Management first reported a position in Charles River Laboratories in Q3 2013 and has held it in 19 quarters since.
  • Sterling Capital Management's Charles River Laboratories position peaked at $1.68M in Q3 2014.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.